Oral Metformin Profoundly Suppresses Atherosclerotic Lesion Development In Vivo Independently of Glucose Lowering in a Mild Hyperlipidemic Model Via AMPK - Boyle,JJ; Seneviratne,AA; Haskard,DO; Carling,D; Hyde,G (KARGER, 2017)